- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04326842
Optical Coherence Tomography Angiography Evaluation of Ocular Changes in Patients With Carotid Artery Stenosis
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
A growing body of research indicates that abnormal ocular microvascular features may serve as a novel biomarker reflecting the severity of underlying cardiovascular, neurodegenerative, and microvascular disease. Since blood flow to the retina is predominantly supplied by the internal carotid artery (ICA), we hypothesized that ocular microvasculature and structure changes may reflect the disease status or therapeutic effects in patients with carotid artery stenosis.
Optical coherence tomography angiography (OCTA) is a novel, non-invasive imaging modality that can be a reliable tool for the qualitative and quantitative assessments of ocular vessels during various ocular pathological or physiological changes. Recent studies have also demonstrated the ability of OCTA to quantify retinal microvascular changes in monitoring cardiovascular risk.
This study aims to evaluate ocular changes in patients with carotid artery stenosis by optical coherence tomography angiography before and after carotid artery revascularization procedure.In this study, the patients with carotid artery stenosis and control group will receive a series of cerebral and ocular examinations including the most important cerebral CT perfusion (CTP) and OCTA. After that, the cerebral and ocular data between the two groups will be compared. Also, the preoperative and postoperative data acquired will be compared.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Heilongjiang
-
Harbin, Heilongjiang, Chine
- The First Affiliated Hospital of Harbin Medical University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Clinical diagnosis of carotid artery stenosis
- Age-gender-race-matched controls
Exclusion Criteria:
- age <18 years
- intraocular pressure (IOP) >21 mmHg
- VA >logMAR 1.0
- spherical equivalent (SE) between >1.00 or < -6.00 D
- other serious eye diseases which may affect OCTA results including diabetic retinopathy, hypertensive retinopathy, retinal vascular occlusion, age-related macular degeneration, and uveitis
- major intraocular surgery performed in the past 6 months or a history of laser photocoagulation or intravitreal injection
- glaucoma or first-degree relatives with a history of glaucoma; and
- any disease that might cause poor scan quality (image quality <6).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Carotid artery stenosis
Patients with carotid artery stenosis.
Procedure: Carotid artery revascularization procedure
|
The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.
Examination will be performed using optical coherence tomography angiography.
This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.
|
|
Control
Patients without carotid artery stenosis
|
Examination will be performed using optical coherence tomography angiography.
This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Radical Peripapillary Capillaries Vessel Density
Délai: Difference of vessel density in each group at baseline
|
Radical peripapillary capillaries vessel density of Optical Coherence Tomography Angiography(OCTA)
|
Difference of vessel density in each group at baseline
|
|
Superficial Vascular Complexes Vessel Density
Délai: Difference of vessel density in each group at baseline
|
superficial vascular complexes vessel density of Optical Coherence Tomography Angiography
|
Difference of vessel density in each group at baseline
|
|
Deep Vascular Complexes Vessel Density
Délai: Difference of vessel density in each group at baseline
|
deep vascular complexes vessel density of Optical Coherence Tomography Angiography
|
Difference of vessel density in each group at baseline
|
|
Choriocapillaris Vessel Density
Délai: Difference of vessel density in each group at baseline
|
choriocapillaris vessel density of Optical Coherence Tomography Angiography
|
Difference of vessel density in each group at baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change of Difference of Mean Transit Time(dMTT)
Délai: baseline and 4 days after carotid artery procedure
|
Change of dMTT is the dMTT value at 4 days after carotid artery procedure minus the value at baseline. dMTT is that the value of the lesion side minus value of contralateral side. Mean transit time (MTT) corresponds to the average time, in seconds, that red blood cells spend within a determinate volume of capillary circulation. |
baseline and 4 days after carotid artery procedure
|
|
Change of the Ratio of Cerebral Blood Flow(rCBF)
Délai: baseline and 4 days after carotid artery procedure
|
Change of rCBF is the rCBF value at 4 days after carotid artery procedure minus the value at baseline. rCBF is that the CBF value of the lesion side divided by the value of contralateral side. CBF refers to the flow of blood through a certain cross-sectional area of cerebrovascular per unit time. |
baseline and 4 days after carotid artery procedure
|
|
Changes of Retinal Nerve Fiber Layer
Délai: baseline and 4 days after carotid artery procedure
|
changes of retinal nerve fiber layer of Optical Coherence Tomography Angiography
|
baseline and 4 days after carotid artery procedure
|
|
Changes of Deep Vascular Complexes Vessel Density
Délai: baseline and 4 days after carotid artery procedure
|
changes of deep vascular complexes vessel density of Optical Coherence Tomography Angiography
|
baseline and 4 days after carotid artery procedure
|
|
Changes of Radical Peripapillary Capillaries Vessel Density
Délai: baseline and 4 days after carotid artery procedure
|
changes of radical peripapillary capillaries vessel density of Optical Coherence Tomography Angiography
|
baseline and 4 days after carotid artery procedure
|
|
Changes of Superficial Vascular Complexes Vessel Density
Délai: baseline and 4 days after carotid artery procedure
|
changes of superficial vascular complexes vessel density of Optical Coherence Tomography Angiography
|
baseline and 4 days after carotid artery procedure
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Hong Zhang, First Affiliated Hospital of Harbin Medical University
- Chercheur principal: Huaizhang Shi, First Affiliated Hospital of Harbin Medical University
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Maladies cardiovasculaires
- Maladies vasculaires
- Troubles cérébrovasculaires
- Maladies du cerveau
- Maladies du système nerveux central
- Maladies du système nerveux
- Maladies artérielles occlusives
- Conditions pathologiques, anatomiques
- Maladies de l'artère carotide
- Sténose carotidienne
- Constriction, Pathologique
Autres numéros d'identification d'étude
- HZHZS1
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .